Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
Corroborated by 2 sources from 2 publishers
globalbusiness1d ago
TL;DR
Strategic Execution and Market Positioning - Ibsrela revenue grew 58% year-over-year, driven by disciplined commercial execution and a strategy focused on positioning the drug as the first-line therapy following secretagogue failure Ardelyx, Inc.